Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Urinary Bladder Neoplasms 14Non-Muscle Invasive Bladder Neoplasms 4Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Sarcoma 1Osteosarcoma 1Neuroblastoma 1Carcinoma, Transitional Cell 1Breast Neoplasms 1

Interventions

Doxorubicin 80Ifosfamide 54Radiotherapy 43Filgrastim 41Gemcitabine 38Cyclophosphamide 34Etoposide 26Vincristine 24Cisplatin 24Docetaxel 23pazopanib 21Trabectedin 19Carboplatin 17pembrolizumab 15Peripheral Blood Stem Cell Transplantation 14eribulin 12Mesna 12Melphalan 12Sorafenib 11Sirolimus 11Irinotecan 11Granulocyte Colony-Stimulating Factor 11Bevacizumab 11Topotecan 10Paclitaxel 10Imatinib Mesylate 10Chemotherapy, Adjuvant 10pegfilgrastim 9Temozolomide 9Surgical Procedures, Operative 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sarcoma × BCG Vaccine × Clear all
NCT00003023 2013-01-18

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
24 enrolled
CNSSarcoma

Neuroblastoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡